Nerviano Medical Sciences

Call
Website

Advertisement

1 Broadway
Cambridge, MA 02142
+1 (781) 531-5009
https://www.nervianoms.com

Nerviano Medical Sciences Srl (NMS) is a biotechnology company specializing in the discovery and clinical development of New Chemical Entities (NCEs) for oncology, including Small Molecules and Antibody-Drug Conjugates (ADCs). The company is committed to delivering innovative cancer treatments by focusing on novel drug targets and mechanisms of action to provide first and best-in-class personalized therapies.

With a strong emphasis on scientific expertise, NMS leverages its capabilities in Small Molecules and ADCs to advance novel therapeutic solutions from discovery through clinical development. Their proven track record highlights their dedication to developing effective oncology drugs that bring hope to patients in need.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Business services, nec, nec

Oxigen USA Inc

Oxigen USA Inc, based in Cambridge, MA, specializes in providing fast and convenient online mobile top-up services to customers worldwide, allowing users to recharge mobile phones for themselves or for loved ones in over 100 countries. With partnerships across more than 220 mobile operators, the company aims to offer the best value and flexibility without the obligations of traditional plans. The platform emphasizes user-friendly navigation, secure payment processes, and a 100% money-back guarantee for unfulfilled transactions. Customers enjoy the convenience of purchasing airtime and data at any time, benefiting from instant top-ups and competitive pricing in a safe online environment. Generated from the website

Pheon Therapeutics Inc

Pheon Therapeutics Inc is a Cambridge, MA-based specialist in Antibody Drug Conjugates (ADCs), focused on developing next-generation therapies for challenging solid tumors. Leveraging over two decades of experience in ADC engineering, the company aims to create innovative treatments by combining monoclonal antibodies with proprietary payloads that enhance efficacy and safety. Committed to addressing unmet medical needs, Pheon is developing a robust pipeline of ADCs targeting difficult-to-treat cancers. The company is guided by a world-class leadership team and supported by expert healthcare investors, underscoring its dedication to clinical advancement and innovation in cancer treatment. Generated from the website

DUNAD Therapeutics

United States›Massachusetts›Cambridge›Nerviano Medical Sciences

Partial Data by Infogroup (c) 2025. All rights reserved.

Advertisement